- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Pharmacodynamics of IMP 08P2002F0 (Fixed dose combination of 0.34% tropicamide and 2.5% phenylephrine hydrochloride, eye drop, Solution) a new ophthalmic mydriatic solution in healthy volunteers.
This study is testing new eye drops designed to make your pupils bigger. We want to see how quickly they work and how long they last. It's for people needing their pupils enlarged for eye exams or surgery.
For: to obtain pre-operative mydriasis or for diagnostic purposesGreece - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in the PDE6B Gene Leading to a Defect in PDE6ß Expression
This study is testing a new gene therapy for people with retinitis pigmentosa caused by a specific faulty gene. It's looking at how safe the treatment is and if it helps improve vision. Researchers are giving the treatment into one eye.
For: retinitis pigmentosaFrance